nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS1—kidney cancer	0.265	0.636	CbGaD
Ketoprofen—PTGS2—kidney cancer	0.151	0.364	CbGaD
Ketoprofen—ABCC4—Sorafenib—kidney cancer	0.058	0.222	CbGbCtD
Ketoprofen—ABCC4—Sunitinib—kidney cancer	0.047	0.18	CbGbCtD
Ketoprofen—CYP2C8—Pazopanib—kidney cancer	0.0286	0.11	CbGbCtD
Ketoprofen—ALB—Erlotinib—kidney cancer	0.0264	0.101	CbGbCtD
Ketoprofen—CYP2C9—Capecitabine—kidney cancer	0.0208	0.0797	CbGbCtD
Ketoprofen—CYP2C8—Erlotinib—kidney cancer	0.0204	0.0782	CbGbCtD
Ketoprofen—CYP2C8—Paclitaxel—kidney cancer	0.0187	0.0716	CbGbCtD
Ketoprofen—CYP2C8—Sorafenib—kidney cancer	0.0166	0.0636	CbGbCtD
Ketoprofen—CYP2C9—Paclitaxel—kidney cancer	0.013	0.0499	CbGbCtD
Ketoprofen—CYP2C9—Sorafenib—kidney cancer	0.0116	0.0444	CbGbCtD
Ketoprofen—SLC22A8—nephron—kidney cancer	0.0046	0.108	CbGeAlD
Ketoprofen—SLC22A8—urine—kidney cancer	0.00369	0.087	CbGeAlD
Ketoprofen—PTGS2—nephron—kidney cancer	0.00261	0.0615	CbGeAlD
Ketoprofen—CYP2C9—urine—kidney cancer	0.0024	0.0565	CbGeAlD
Ketoprofen—CXCL8—nephron tubule—kidney cancer	0.00213	0.0501	CbGeAlD
Ketoprofen—SLC22A11—nephron tubule—kidney cancer	0.00176	0.0415	CbGeAlD
Ketoprofen—SLC22A6—nephron tubule—kidney cancer	0.00166	0.0391	CbGeAlD
Ketoprofen—SLC22A11—renal system—kidney cancer	0.0016	0.0377	CbGeAlD
Ketoprofen—SLC22A7—renal system—kidney cancer	0.00156	0.0368	CbGeAlD
Ketoprofen—SLC22A11—kidney—kidney cancer	0.00155	0.0365	CbGeAlD
Ketoprofen—SLC22A7—kidney—kidney cancer	0.00151	0.0356	CbGeAlD
Ketoprofen—SLC22A11—cortex of kidney—kidney cancer	0.00151	0.0355	CbGeAlD
Ketoprofen—SLC22A7—cortex of kidney—kidney cancer	0.00147	0.0347	CbGeAlD
Ketoprofen—SLC22A6—cortex of kidney—kidney cancer	0.00142	0.0335	CbGeAlD
Ketoprofen—ABCC4—nephron tubule—kidney cancer	0.001	0.0236	CbGeAlD
Ketoprofen—SLC22A8—nephron tubule—kidney cancer	0.000993	0.0234	CbGeAlD
Ketoprofen—SLCO1A2—renal system—kidney cancer	0.000946	0.0223	CbGeAlD
Ketoprofen—SLCO1A2—kidney—kidney cancer	0.000914	0.0215	CbGeAlD
Ketoprofen—ABCC4—renal system—kidney cancer	0.00091	0.0214	CbGeAlD
Ketoprofen—SLC22A8—renal system—kidney cancer	0.000903	0.0213	CbGeAlD
Ketoprofen—ABCC4—kidney—kidney cancer	0.00088	0.0207	CbGeAlD
Ketoprofen—SLC22A8—kidney—kidney cancer	0.000873	0.0206	CbGeAlD
Ketoprofen—ABCC4—cortex of kidney—kidney cancer	0.000857	0.0202	CbGeAlD
Ketoprofen—SLC22A8—cortex of kidney—kidney cancer	0.00085	0.02	CbGeAlD
Ketoprofen—CYP2C8—renal system—kidney cancer	0.000661	0.0156	CbGeAlD
Ketoprofen—CYP2C8—kidney—kidney cancer	0.000639	0.0151	CbGeAlD
Ketoprofen—PTGS1—renal system—kidney cancer	0.000536	0.0126	CbGeAlD
Ketoprofen—PTGS1—kidney—kidney cancer	0.000518	0.0122	CbGeAlD
Ketoprofen—PTGS2—renal system—kidney cancer	0.000512	0.0121	CbGeAlD
Ketoprofen—PTGS2—kidney—kidney cancer	0.000495	0.0117	CbGeAlD
Ketoprofen—PTGS1—cardiac atrium—kidney cancer	0.00048	0.0113	CbGeAlD
Ketoprofen—Carprofen—PTGS1—kidney cancer	0.000367	0.0633	CrCbGaD
Ketoprofen—Ketorolac—PTGS1—kidney cancer	0.000367	0.0633	CrCbGaD
Ketoprofen—Bromfenac—PTGS1—kidney cancer	0.000352	0.0607	CrCbGaD
Ketoprofen—Tiaprofenic acid—PTGS1—kidney cancer	0.000299	0.0516	CrCbGaD
Ketoprofen—Nepafenac—PTGS1—kidney cancer	0.000285	0.0491	CrCbGaD
Ketoprofen—Magnesium salicylate—PTGS1—kidney cancer	0.000278	0.048	CrCbGaD
Ketoprofen—Fenbufen—PTGS1—kidney cancer	0.000272	0.0469	CrCbGaD
Ketoprofen—Mebendazole—CYP1A1—kidney cancer	0.000244	0.042	CrCbGaD
Ketoprofen—Salsalate—PTGS1—kidney cancer	0.000237	0.0408	CrCbGaD
Ketoprofen—Suprofen—PTGS1—kidney cancer	0.000227	0.0391	CrCbGaD
Ketoprofen—Carprofen—PTGS2—kidney cancer	0.00021	0.0362	CrCbGaD
Ketoprofen—Ketorolac—PTGS2—kidney cancer	0.00021	0.0362	CrCbGaD
Ketoprofen—Bromfenac—PTGS2—kidney cancer	0.000201	0.0347	CrCbGaD
Ketoprofen—Fenoprofen—PTGS1—kidney cancer	0.000196	0.0337	CrCbGaD
Ketoprofen—Mefenamic acid—PTGS1—kidney cancer	0.000181	0.0313	CrCbGaD
Ketoprofen—Naproxen—PTGS1—kidney cancer	0.000178	0.0307	CrCbGaD
Ketoprofen—Tiaprofenic acid—PTGS2—kidney cancer	0.000171	0.0295	CrCbGaD
Ketoprofen—Nepafenac—PTGS2—kidney cancer	0.000163	0.028	CrCbGaD
Ketoprofen—Magnesium salicylate—PTGS2—kidney cancer	0.000159	0.0274	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—kidney cancer	0.000156	0.0268	CrCbGaD
Ketoprofen—Warfarin—CYP1A1—kidney cancer	0.000137	0.0236	CrCbGaD
Ketoprofen—Salsalate—PTGS2—kidney cancer	0.000135	0.0233	CrCbGaD
Ketoprofen—Mebendazole—ABCB1—kidney cancer	0.00013	0.0223	CrCbGaD
Ketoprofen—Suprofen—PTGS2—kidney cancer	0.00013	0.0223	CrCbGaD
Ketoprofen—Flurbiprofen—PTGS1—kidney cancer	0.000128	0.022	CrCbGaD
Ketoprofen—Renal impairment—Doxorubicin—kidney cancer	0.00012	0.000632	CcSEcCtD
Ketoprofen—Paraesthesia—Vincristine—kidney cancer	0.00012	0.000632	CcSEcCtD
Ketoprofen—Dermatitis bullous—Doxorubicin—kidney cancer	0.00012	0.000629	CcSEcCtD
Ketoprofen—Rash—Everolimus—kidney cancer	0.00012	0.000628	CcSEcCtD
Ketoprofen—Dermatitis—Everolimus—kidney cancer	0.00012	0.000627	CcSEcCtD
Ketoprofen—Headache—Vinblastine—kidney cancer	0.000119	0.000626	CcSEcCtD
Ketoprofen—Angioedema—Paclitaxel—kidney cancer	0.000119	0.000625	CcSEcCtD
Ketoprofen—Purpura—Doxorubicin—kidney cancer	0.000119	0.000624	CcSEcCtD
Ketoprofen—Headache—Everolimus—kidney cancer	0.000119	0.000624	CcSEcCtD
Ketoprofen—Abdominal pain—Dactinomycin—kidney cancer	0.000119	0.000622	CcSEcCtD
Ketoprofen—Visual impairment—Capecitabine—kidney cancer	0.000119	0.000622	CcSEcCtD
Ketoprofen—Asthenia—Sorafenib—kidney cancer	0.000118	0.00062	CcSEcCtD
Ketoprofen—Malaise—Paclitaxel—kidney cancer	0.000118	0.000617	CcSEcCtD
Ketoprofen—Cardiac failure—Doxorubicin—kidney cancer	0.000117	0.000616	CcSEcCtD
Ketoprofen—Vertigo—Paclitaxel—kidney cancer	0.000117	0.000615	CcSEcCtD
Ketoprofen—Hypersensitivity—Sunitinib—kidney cancer	0.000117	0.000613	CcSEcCtD
Ketoprofen—Decreased appetite—Vincristine—kidney cancer	0.000117	0.000611	CcSEcCtD
Ketoprofen—Pruritus—Sorafenib—kidney cancer	0.000117	0.000611	CcSEcCtD
Ketoprofen—Vomiting—Erlotinib—kidney cancer	0.000116	0.000611	CcSEcCtD
Ketoprofen—Erythema multiforme—Capecitabine—kidney cancer	0.000116	0.00061	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000116	0.000608	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Vincristine—kidney cancer	0.000116	0.000607	CcSEcCtD
Ketoprofen—Fatigue—Vincristine—kidney cancer	0.000116	0.000606	CcSEcCtD
Ketoprofen—Rash—Erlotinib—kidney cancer	0.000115	0.000606	CcSEcCtD
Ketoprofen—Dermatitis—Erlotinib—kidney cancer	0.000115	0.000605	CcSEcCtD
Ketoprofen—Palpitations—Paclitaxel—kidney cancer	0.000115	0.000605	CcSEcCtD
Ketoprofen—Hyponatraemia—Doxorubicin—kidney cancer	0.000115	0.000604	CcSEcCtD
Ketoprofen—Insomnia—Gemcitabine—kidney cancer	0.000115	0.000603	CcSEcCtD
Ketoprofen—Headache—Erlotinib—kidney cancer	0.000115	0.000602	CcSEcCtD
Ketoprofen—Tinnitus—Capecitabine—kidney cancer	0.000115	0.000602	CcSEcCtD
Ketoprofen—Constipation—Vincristine—kidney cancer	0.000115	0.000601	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000115	0.000601	CcSEcCtD
Ketoprofen—Paraesthesia—Gemcitabine—kidney cancer	0.000114	0.000599	CcSEcCtD
Ketoprofen—Flushing—Capecitabine—kidney cancer	0.000114	0.000599	CcSEcCtD
Ketoprofen—Asthenia—Sunitinib—kidney cancer	0.000114	0.000597	CcSEcCtD
Ketoprofen—Dyspnoea—Gemcitabine—kidney cancer	0.000113	0.000595	CcSEcCtD
Ketoprofen—Nausea—Vinblastine—kidney cancer	0.000113	0.000594	CcSEcCtD
Ketoprofen—Somnolence—Gemcitabine—kidney cancer	0.000113	0.000593	CcSEcCtD
Ketoprofen—Convulsion—Paclitaxel—kidney cancer	0.000113	0.000593	CcSEcCtD
Ketoprofen—Migraine—Doxorubicin—kidney cancer	0.000113	0.000592	CcSEcCtD
Ketoprofen—Nausea—Everolimus—kidney cancer	0.000113	0.000591	CcSEcCtD
Ketoprofen—Diarrhoea—Sorafenib—kidney cancer	0.000113	0.000591	CcSEcCtD
Ketoprofen—Hypertension—Paclitaxel—kidney cancer	0.000113	0.000591	CcSEcCtD
Ketoprofen—Pruritus—Sunitinib—kidney cancer	0.000112	0.000588	CcSEcCtD
Ketoprofen—Fenoprofen—PTGS2—kidney cancer	0.000112	0.0193	CrCbGaD
Ketoprofen—Myalgia—Paclitaxel—kidney cancer	0.000111	0.000583	CcSEcCtD
Ketoprofen—Anxiety—Paclitaxel—kidney cancer	0.000111	0.000581	CcSEcCtD
Ketoprofen—Face oedema—Doxorubicin—kidney cancer	0.000111	0.00058	CcSEcCtD
Ketoprofen—Decreased appetite—Gemcitabine—kidney cancer	0.000111	0.00058	CcSEcCtD
Ketoprofen—Hypersensitivity—Dactinomycin—kidney cancer	0.000111	0.00058	CcSEcCtD
Ketoprofen—Chills—Capecitabine—kidney cancer	0.00011	0.000579	CcSEcCtD
Ketoprofen—Arrhythmia—Capecitabine—kidney cancer	0.00011	0.000576	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00011	0.000576	CcSEcCtD
Ketoprofen—Discomfort—Paclitaxel—kidney cancer	0.00011	0.000576	CcSEcCtD
Ketoprofen—Fatigue—Gemcitabine—kidney cancer	0.00011	0.000575	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Vincristine—kidney cancer	0.00011	0.000575	CcSEcCtD
Ketoprofen—Dizziness—Sorafenib—kidney cancer	0.000109	0.000571	CcSEcCtD
Ketoprofen—Constipation—Gemcitabine—kidney cancer	0.000109	0.000571	CcSEcCtD
Ketoprofen—Nausea—Erlotinib—kidney cancer	0.000109	0.000571	CcSEcCtD
Ketoprofen—Alopecia—Capecitabine—kidney cancer	0.000109	0.00057	CcSEcCtD
Ketoprofen—Dry mouth—Paclitaxel—kidney cancer	0.000109	0.00057	CcSEcCtD
Ketoprofen—Diarrhoea—Sunitinib—kidney cancer	0.000108	0.000569	CcSEcCtD
Ketoprofen—Asthenia—Dactinomycin—kidney cancer	0.000108	0.000565	CcSEcCtD
Ketoprofen—Confusional state—Paclitaxel—kidney cancer	0.000107	0.000563	CcSEcCtD
Ketoprofen—Erythema—Capecitabine—kidney cancer	0.000107	0.000562	CcSEcCtD
Ketoprofen—Anaphylactic shock—Paclitaxel—kidney cancer	0.000107	0.000559	CcSEcCtD
Ketoprofen—Oedema—Paclitaxel—kidney cancer	0.000107	0.000559	CcSEcCtD
Ketoprofen—Abdominal pain—Vincristine—kidney cancer	0.000106	0.000556	CcSEcCtD
Ketoprofen—Infection—Paclitaxel—kidney cancer	0.000106	0.000555	CcSEcCtD
Ketoprofen—Flatulence—Capecitabine—kidney cancer	0.000106	0.000554	CcSEcCtD
Ketoprofen—Dysgeusia—Capecitabine—kidney cancer	0.000105	0.00055	CcSEcCtD
Ketoprofen—Dizziness—Sunitinib—kidney cancer	0.000105	0.00055	CcSEcCtD
Ketoprofen—Feeling abnormal—Gemcitabine—kidney cancer	0.000105	0.00055	CcSEcCtD
Ketoprofen—Shock—Paclitaxel—kidney cancer	0.000105	0.00055	CcSEcCtD
Ketoprofen—Vomiting—Sorafenib—kidney cancer	0.000105	0.000549	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—kidney cancer	0.000105	0.000549	CcSEcCtD
Ketoprofen—Thrombocytopenia—Paclitaxel—kidney cancer	0.000104	0.000547	CcSEcCtD
Ketoprofen—Tachycardia—Paclitaxel—kidney cancer	0.000104	0.000545	CcSEcCtD
Ketoprofen—Rash—Sorafenib—kidney cancer	0.000104	0.000545	CcSEcCtD
Ketoprofen—Dermatitis—Sorafenib—kidney cancer	0.000104	0.000544	CcSEcCtD
Ketoprofen—Mefenamic acid—PTGS2—kidney cancer	0.000104	0.0179	CrCbGaD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000103	0.000541	CcSEcCtD
Ketoprofen—Headache—Sorafenib—kidney cancer	0.000103	0.000541	CcSEcCtD
Ketoprofen—Hyperhidrosis—Paclitaxel—kidney cancer	0.000103	0.00054	CcSEcCtD
Ketoprofen—Diarrhoea—Dactinomycin—kidney cancer	0.000103	0.000539	CcSEcCtD
Ketoprofen—Naproxen—PTGS2—kidney cancer	0.000102	0.0175	CrCbGaD
Ketoprofen—Anorexia—Paclitaxel—kidney cancer	0.000102	0.000533	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—kidney cancer	0.000101	0.000532	CcSEcCtD
Ketoprofen—Vomiting—Sunitinib—kidney cancer	0.000101	0.000529	CcSEcCtD
Ketoprofen—Rash—Sunitinib—kidney cancer	0.0001	0.000524	CcSEcCtD
Ketoprofen—Dermatitis—Sunitinib—kidney cancer	9.99e-05	0.000524	CcSEcCtD
Ketoprofen—Ill-defined disorder—Capecitabine—kidney cancer	9.94e-05	0.000521	CcSEcCtD
Ketoprofen—Headache—Sunitinib—kidney cancer	9.93e-05	0.000521	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—kidney cancer	9.91e-05	0.00052	CcSEcCtD
Ketoprofen—Anaemia—Capecitabine—kidney cancer	9.9e-05	0.000519	CcSEcCtD
Ketoprofen—Hypersensitivity—Vincristine—kidney cancer	9.88e-05	0.000518	CcSEcCtD
Ketoprofen—Nausea—Sorafenib—kidney cancer	9.79e-05	0.000513	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—kidney cancer	9.71e-05	0.00051	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Paclitaxel—kidney cancer	9.7e-05	0.000509	CcSEcCtD
Ketoprofen—Malaise—Capecitabine—kidney cancer	9.66e-05	0.000507	CcSEcCtD
Ketoprofen—Insomnia—Paclitaxel—kidney cancer	9.63e-05	0.000505	CcSEcCtD
Ketoprofen—Vertigo—Capecitabine—kidney cancer	9.62e-05	0.000505	CcSEcCtD
Ketoprofen—Asthenia—Vincristine—kidney cancer	9.62e-05	0.000505	CcSEcCtD
Ketoprofen—Paraesthesia—Paclitaxel—kidney cancer	9.56e-05	0.000502	CcSEcCtD
Ketoprofen—Vomiting—Dactinomycin—kidney cancer	9.54e-05	0.000501	CcSEcCtD
Ketoprofen—Dyspnoea—Paclitaxel—kidney cancer	9.5e-05	0.000498	CcSEcCtD
Ketoprofen—Somnolence—Paclitaxel—kidney cancer	9.47e-05	0.000497	CcSEcCtD
Ketoprofen—Palpitations—Capecitabine—kidney cancer	9.46e-05	0.000496	CcSEcCtD
Ketoprofen—Rash—Dactinomycin—kidney cancer	9.46e-05	0.000496	CcSEcCtD
Ketoprofen—Nausea—Sunitinib—kidney cancer	9.42e-05	0.000494	CcSEcCtD
Ketoprofen—Dyspepsia—Paclitaxel—kidney cancer	9.38e-05	0.000492	CcSEcCtD
Ketoprofen—Decreased appetite—Paclitaxel—kidney cancer	9.26e-05	0.000486	CcSEcCtD
Ketoprofen—Hypertension—Capecitabine—kidney cancer	9.25e-05	0.000485	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Paclitaxel—kidney cancer	9.2e-05	0.000482	CcSEcCtD
Ketoprofen—Fatigue—Paclitaxel—kidney cancer	9.18e-05	0.000482	CcSEcCtD
Ketoprofen—Diarrhoea—Vincristine—kidney cancer	9.18e-05	0.000481	CcSEcCtD
Ketoprofen—Asthenia—Gemcitabine—kidney cancer	9.13e-05	0.000479	CcSEcCtD
Ketoprofen—Myalgia—Capecitabine—kidney cancer	9.12e-05	0.000478	CcSEcCtD
Ketoprofen—Constipation—Paclitaxel—kidney cancer	9.11e-05	0.000478	CcSEcCtD
Ketoprofen—Anxiety—Capecitabine—kidney cancer	9.09e-05	0.000477	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—kidney cancer	9.04e-05	0.000474	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—kidney cancer	9.02e-05	0.000473	CcSEcCtD
Ketoprofen—Discomfort—Capecitabine—kidney cancer	9.01e-05	0.000473	CcSEcCtD
Ketoprofen—Pruritus—Gemcitabine—kidney cancer	9e-05	0.000472	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—kidney cancer	8.96e-05	0.00047	CcSEcCtD
Ketoprofen—Dry mouth—Capecitabine—kidney cancer	8.92e-05	0.000468	CcSEcCtD
Ketoprofen—Nausea—Dactinomycin—kidney cancer	8.92e-05	0.000468	CcSEcCtD
Ketoprofen—Dizziness—Vincristine—kidney cancer	8.87e-05	0.000465	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—kidney cancer	8.83e-05	0.000463	CcSEcCtD
Ketoprofen—Confusional state—Capecitabine—kidney cancer	8.81e-05	0.000462	CcSEcCtD
Ketoprofen—Feeling abnormal—Paclitaxel—kidney cancer	8.78e-05	0.00046	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	8.76e-05	0.000459	CcSEcCtD
Ketoprofen—Oedema—Capecitabine—kidney cancer	8.74e-05	0.000458	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Paclitaxel—kidney cancer	8.71e-05	0.000457	CcSEcCtD
Ketoprofen—Diarrhoea—Gemcitabine—kidney cancer	8.7e-05	0.000457	CcSEcCtD
Ketoprofen—Renal failure—Doxorubicin—kidney cancer	8.68e-05	0.000455	CcSEcCtD
Ketoprofen—Infection—Capecitabine—kidney cancer	8.68e-05	0.000455	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—kidney cancer	8.61e-05	0.000452	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—kidney cancer	8.61e-05	0.000452	CcSEcCtD
Ketoprofen—Shock—Capecitabine—kidney cancer	8.6e-05	0.000451	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—kidney cancer	8.59e-05	0.00045	CcSEcCtD
Ketoprofen—Thrombocytopenia—Capecitabine—kidney cancer	8.56e-05	0.000449	CcSEcCtD
Ketoprofen—Tachycardia—Capecitabine—kidney cancer	8.53e-05	0.000447	CcSEcCtD
Ketoprofen—Vomiting—Vincristine—kidney cancer	8.53e-05	0.000447	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—kidney cancer	8.47e-05	0.000444	CcSEcCtD
Ketoprofen—Urticaria—Paclitaxel—kidney cancer	8.46e-05	0.000444	CcSEcCtD
Ketoprofen—Rash—Vincristine—kidney cancer	8.46e-05	0.000443	CcSEcCtD
Ketoprofen—Hyperhidrosis—Capecitabine—kidney cancer	8.45e-05	0.000443	CcSEcCtD
Ketoprofen—Dermatitis—Vincristine—kidney cancer	8.45e-05	0.000443	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—kidney cancer	8.42e-05	0.000442	CcSEcCtD
Ketoprofen—Abdominal pain—Paclitaxel—kidney cancer	8.42e-05	0.000442	CcSEcCtD
Ketoprofen—Headache—Vincristine—kidney cancer	8.4e-05	0.000441	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—kidney cancer	8.33e-05	0.000437	CcSEcCtD
Ketoprofen—Anorexia—Capecitabine—kidney cancer	8.33e-05	0.000437	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—kidney cancer	8.24e-05	0.000432	CcSEcCtD
Ketoprofen—Vomiting—Gemcitabine—kidney cancer	8.09e-05	0.000424	CcSEcCtD
Ketoprofen—Rash—Gemcitabine—kidney cancer	8.02e-05	0.000421	CcSEcCtD
Ketoprofen—Dermatitis—Gemcitabine—kidney cancer	8.01e-05	0.00042	CcSEcCtD
Ketoprofen—Headache—Gemcitabine—kidney cancer	7.97e-05	0.000418	CcSEcCtD
Ketoprofen—Nausea—Vincristine—kidney cancer	7.97e-05	0.000418	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.96e-05	0.000418	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—kidney cancer	7.95e-05	0.000417	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—kidney cancer	7.93e-05	0.000416	CcSEcCtD
Ketoprofen—Insomnia—Capecitabine—kidney cancer	7.91e-05	0.000415	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—kidney cancer	7.87e-05	0.000413	CcSEcCtD
Ketoprofen—Paraesthesia—Capecitabine—kidney cancer	7.85e-05	0.000412	CcSEcCtD
Ketoprofen—Hypersensitivity—Paclitaxel—kidney cancer	7.85e-05	0.000412	CcSEcCtD
Ketoprofen—Dyspnoea—Capecitabine—kidney cancer	7.79e-05	0.000409	CcSEcCtD
Ketoprofen—Dyspepsia—Capecitabine—kidney cancer	7.69e-05	0.000404	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—kidney cancer	7.64e-05	0.000401	CcSEcCtD
Ketoprofen—Asthenia—Paclitaxel—kidney cancer	7.64e-05	0.000401	CcSEcCtD
Ketoprofen—Decreased appetite—Capecitabine—kidney cancer	7.6e-05	0.000399	CcSEcCtD
Ketoprofen—Nausea—Gemcitabine—kidney cancer	7.56e-05	0.000396	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Capecitabine—kidney cancer	7.55e-05	0.000396	CcSEcCtD
Ketoprofen—Fatigue—Capecitabine—kidney cancer	7.54e-05	0.000395	CcSEcCtD
Ketoprofen—Pruritus—Paclitaxel—kidney cancer	7.54e-05	0.000395	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—kidney cancer	7.5e-05	0.000393	CcSEcCtD
Ketoprofen—Constipation—Capecitabine—kidney cancer	7.47e-05	0.000392	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—kidney cancer	7.39e-05	0.000388	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—kidney cancer	7.36e-05	0.000386	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS2—kidney cancer	7.3e-05	0.0126	CrCbGaD
Ketoprofen—Diarrhoea—Paclitaxel—kidney cancer	7.29e-05	0.000382	CcSEcCtD
Ketoprofen—Feeling abnormal—Capecitabine—kidney cancer	7.2e-05	0.000378	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Capecitabine—kidney cancer	7.15e-05	0.000375	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—kidney cancer	7.12e-05	0.000373	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—kidney cancer	7.08e-05	0.000372	CcSEcCtD
Ketoprofen—Dizziness—Paclitaxel—kidney cancer	7.04e-05	0.000369	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—kidney cancer	7.01e-05	0.000368	CcSEcCtD
Ketoprofen—Urticaria—Capecitabine—kidney cancer	6.94e-05	0.000364	CcSEcCtD
Ketoprofen—Abdominal pain—Capecitabine—kidney cancer	6.91e-05	0.000362	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—kidney cancer	6.9e-05	0.000362	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—kidney cancer	6.8e-05	0.000357	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—kidney cancer	6.77e-05	0.000355	CcSEcCtD
Ketoprofen—Vomiting—Paclitaxel—kidney cancer	6.77e-05	0.000355	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—kidney cancer	6.76e-05	0.000355	CcSEcCtD
Ketoprofen—Rash—Paclitaxel—kidney cancer	6.72e-05	0.000352	CcSEcCtD
Ketoprofen—Dermatitis—Paclitaxel—kidney cancer	6.71e-05	0.000352	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—kidney cancer	6.71e-05	0.000352	CcSEcCtD
Ketoprofen—Headache—Paclitaxel—kidney cancer	6.67e-05	0.00035	CcSEcCtD
Ketoprofen—Hypersensitivity—Capecitabine—kidney cancer	6.44e-05	0.000338	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—kidney cancer	6.41e-05	0.000336	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—kidney cancer	6.38e-05	0.000335	CcSEcCtD
Ketoprofen—Nausea—Paclitaxel—kidney cancer	6.33e-05	0.000332	CcSEcCtD
Ketoprofen—Asthenia—Capecitabine—kidney cancer	6.27e-05	0.000329	CcSEcCtD
Ketoprofen—Malaise—Doxorubicin—kidney cancer	6.23e-05	0.000327	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—kidney cancer	6.2e-05	0.000325	CcSEcCtD
Ketoprofen—Pruritus—Capecitabine—kidney cancer	6.18e-05	0.000324	CcSEcCtD
Ketoprofen—Palpitations—Doxorubicin—kidney cancer	6.1e-05	0.00032	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—kidney cancer	5.98e-05	0.000314	CcSEcCtD
Ketoprofen—Diarrhoea—Capecitabine—kidney cancer	5.98e-05	0.000314	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—kidney cancer	5.96e-05	0.000313	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—kidney cancer	5.88e-05	0.000308	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—kidney cancer	5.86e-05	0.000307	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—kidney cancer	5.81e-05	0.000305	CcSEcCtD
Ketoprofen—Dizziness—Capecitabine—kidney cancer	5.78e-05	0.000303	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—kidney cancer	5.75e-05	0.000301	CcSEcCtD
Ketoprofen—Confusional state—Doxorubicin—kidney cancer	5.68e-05	0.000298	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—kidney cancer	5.63e-05	0.000296	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—kidney cancer	5.63e-05	0.000296	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—kidney cancer	5.6e-05	0.000294	CcSEcCtD
Ketoprofen—Vomiting—Capecitabine—kidney cancer	5.56e-05	0.000291	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—kidney cancer	5.54e-05	0.000291	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—kidney cancer	5.52e-05	0.000289	CcSEcCtD
Ketoprofen—Rash—Capecitabine—kidney cancer	5.51e-05	0.000289	CcSEcCtD
Ketoprofen—Dermatitis—Capecitabine—kidney cancer	5.51e-05	0.000289	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—kidney cancer	5.5e-05	0.000288	CcSEcCtD
Ketoprofen—Headache—Capecitabine—kidney cancer	5.48e-05	0.000287	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—kidney cancer	5.45e-05	0.000286	CcSEcCtD
Ketoprofen—Anorexia—Doxorubicin—kidney cancer	5.37e-05	0.000282	CcSEcCtD
Ketoprofen—Nausea—Capecitabine—kidney cancer	5.19e-05	0.000272	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.13e-05	0.000269	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—kidney cancer	5.1e-05	0.000267	CcSEcCtD
Ketoprofen—Paraesthesia—Doxorubicin—kidney cancer	5.06e-05	0.000265	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—kidney cancer	5.02e-05	0.000263	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—kidney cancer	5.01e-05	0.000263	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—kidney cancer	4.96e-05	0.00026	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—kidney cancer	4.9e-05	0.000257	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.86e-05	0.000255	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—kidney cancer	4.86e-05	0.000255	CcSEcCtD
Ketoprofen—Constipation—Doxorubicin—kidney cancer	4.82e-05	0.000253	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—kidney cancer	4.64e-05	0.000244	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—kidney cancer	4.61e-05	0.000242	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—kidney cancer	4.48e-05	0.000235	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—kidney cancer	4.45e-05	0.000234	CcSEcCtD
Ketoprofen—Hypersensitivity—Doxorubicin—kidney cancer	4.15e-05	0.000218	CcSEcCtD
Ketoprofen—Asthenia—Doxorubicin—kidney cancer	4.04e-05	0.000212	CcSEcCtD
Ketoprofen—Pruritus—Doxorubicin—kidney cancer	3.99e-05	0.000209	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—kidney cancer	3.86e-05	0.000202	CcSEcCtD
Ketoprofen—Dizziness—Doxorubicin—kidney cancer	3.73e-05	0.000195	CcSEcCtD
Ketoprofen—Vomiting—Doxorubicin—kidney cancer	3.58e-05	0.000188	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—kidney cancer	3.55e-05	0.000186	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—kidney cancer	3.55e-05	0.000186	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—kidney cancer	3.53e-05	0.000185	CcSEcCtD
Ketoprofen—Nausea—Doxorubicin—kidney cancer	3.35e-05	0.000176	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—SLC5A5—kidney cancer	1.64e-05	0.000196	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—CTNNB1—kidney cancer	1.63e-05	0.000196	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—RAF1—kidney cancer	1.63e-05	0.000195	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.63e-05	0.000195	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ST3GAL2—kidney cancer	1.62e-05	0.000194	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL2—kidney cancer	1.62e-05	0.000193	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.62e-05	0.000193	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.61e-05	0.000192	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.6e-05	0.000191	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CA9—kidney cancer	1.59e-05	0.000191	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.59e-05	0.00019	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ITPR2—kidney cancer	1.59e-05	0.00019	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ALDH1A1—kidney cancer	1.58e-05	0.000189	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—SLC2A1—kidney cancer	1.58e-05	0.000189	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCND1—kidney cancer	1.58e-05	0.000189	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—JUN—kidney cancer	1.57e-05	0.000188	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.57e-05	0.000188	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CTNNB1—kidney cancer	1.56e-05	0.000187	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.56e-05	0.000186	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IGF2—kidney cancer	1.55e-05	0.000185	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.53e-05	0.000183	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.52e-05	0.000182	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PGK1—kidney cancer	1.52e-05	0.000182	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—FH—kidney cancer	1.52e-05	0.000182	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APRT—kidney cancer	1.52e-05	0.000182	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PTEN—kidney cancer	1.52e-05	0.000182	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PGK1—kidney cancer	1.52e-05	0.000181	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC5A3—kidney cancer	1.52e-05	0.000181	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.51e-05	0.00018	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ITPR2—kidney cancer	1.5e-05	0.00018	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—LDHB—kidney cancer	1.5e-05	0.000179	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.49e-05	0.000178	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—LDHB—kidney cancer	1.49e-05	0.000178	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.49e-05	0.000178	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.48e-05	0.000177	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF2—kidney cancer	1.48e-05	0.000177	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN2B—kidney cancer	1.47e-05	0.000176	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.46e-05	0.000175	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ACHE—kidney cancer	1.45e-05	0.000173	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTT1—kidney cancer	1.45e-05	0.000173	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—kidney cancer	1.43e-05	0.000171	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GPC3—kidney cancer	1.43e-05	0.000171	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1R—kidney cancer	1.43e-05	0.000171	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.42e-05	0.000169	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CA2—kidney cancer	1.39e-05	0.000167	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—RAF1—kidney cancer	1.38e-05	0.000165	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—kidney cancer	1.37e-05	0.000164	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SCARB1—kidney cancer	1.37e-05	0.000164	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.36e-05	0.000163	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—IL2—kidney cancer	1.36e-05	0.000163	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALAD—kidney cancer	1.36e-05	0.000162	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—MAPK3—kidney cancer	1.36e-05	0.000162	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CRABP1—kidney cancer	1.35e-05	0.000162	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.34e-05	0.00016	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PSMD7—kidney cancer	1.33e-05	0.000159	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.32e-05	0.000158	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.32e-05	0.000158	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GSTP1—kidney cancer	1.32e-05	0.000158	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.3e-05	0.000156	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MAPK3—kidney cancer	1.3e-05	0.000155	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CA9—kidney cancer	1.3e-05	0.000155	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.29e-05	0.000155	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—MAPK1—kidney cancer	1.29e-05	0.000154	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CA9—kidney cancer	1.29e-05	0.000154	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.27e-05	0.000152	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—BCHE—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PSMD7—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ITPR2—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.26e-05	0.00015	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ABCB1—kidney cancer	1.25e-05	0.000149	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC5A5—kidney cancer	1.24e-05	0.000149	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PGK1—kidney cancer	1.24e-05	0.000148	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.24e-05	0.000148	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MAPK1—kidney cancer	1.24e-05	0.000148	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL2—kidney cancer	1.24e-05	0.000148	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—kidney cancer	1.22e-05	0.000146	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—LDHB—kidney cancer	1.22e-05	0.000146	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GSTM1—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC2A1—kidney cancer	1.2e-05	0.000144	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.19e-05	0.000142	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HIF1A—kidney cancer	1.18e-05	0.000141	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TSC2—kidney cancer	1.17e-05	0.00014	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—kidney cancer	1.17e-05	0.00014	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.17e-05	0.00014	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.16e-05	0.000139	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTT1—kidney cancer	1.15e-05	0.000137	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ACHE—kidney cancer	1.15e-05	0.000137	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP1A1—kidney cancer	1.15e-05	0.000137	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SLC2A1—kidney cancer	1.14e-05	0.000136	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.13e-05	0.000135	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—JUNB—kidney cancer	1.13e-05	0.000135	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KDR—kidney cancer	1.13e-05	0.000135	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PIK3CA—kidney cancer	1.12e-05	0.000134	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CRABP1—kidney cancer	1.1e-05	0.000132	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CRABP1—kidney cancer	1.1e-05	0.000131	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SCARB1—kidney cancer	1.09e-05	0.00013	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—kidney cancer	1.08e-05	0.000129	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTGS1—kidney cancer	1.08e-05	0.000129	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PIK3CA—kidney cancer	1.07e-05	0.000128	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PSMD7—kidney cancer	1.06e-05	0.000126	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CA9—kidney cancer	1.06e-05	0.000126	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—kidney cancer	1.04e-05	0.000124	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KIT—kidney cancer	1.04e-05	0.000124	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APC—kidney cancer	1.04e-05	0.000124	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.03e-05	0.000123	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ITPR2—kidney cancer	1.02e-05	0.000123	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ITPR2—kidney cancer	1.02e-05	0.000122	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.02e-05	0.000122	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTP1—kidney cancer	1e-05	0.00012	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—BCHE—kidney cancer	1e-05	0.00012	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—MAPK3—kidney cancer	9.93e-06	0.000119	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC5A5—kidney cancer	9.88e-06	0.000118	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—POMC—kidney cancer	9.87e-06	0.000118	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	9.82e-06	0.000118	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—BRAF—kidney cancer	9.75e-06	0.000117	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC2A1—kidney cancer	9.55e-06	0.000114	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ABCB1—kidney cancer	9.49e-06	0.000114	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—MAPK1—kidney cancer	9.45e-06	0.000113	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.45e-06	0.000113	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.43e-06	0.000113	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.39e-06	0.000112	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ACHE—kidney cancer	9.35e-06	0.000112	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTT1—kidney cancer	9.35e-06	0.000112	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTT1—kidney cancer	9.29e-06	0.000111	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ACHE—kidney cancer	9.29e-06	0.000111	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTM1—kidney cancer	9.22e-06	0.00011	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN2B—kidney cancer	9.21e-06	0.00011	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CA—kidney cancer	9.03e-06	0.000108	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CRABP1—kidney cancer	8.97e-06	0.000107	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—kidney cancer	8.92e-06	0.000107	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SCARB1—kidney cancer	8.85e-06	0.000106	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SCARB1—kidney cancer	8.8e-06	0.000105	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS1—kidney cancer	8.76e-06	0.000105	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP1A1—kidney cancer	8.74e-06	0.000105	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS1—kidney cancer	8.71e-06	0.000104	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PSMD7—kidney cancer	8.59e-06	0.000103	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—POMC—kidney cancer	8.56e-06	0.000102	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PSMD7—kidney cancer	8.54e-06	0.000102	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—RAF1—kidney cancer	8.51e-06	0.000102	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ITPR2—kidney cancer	8.34e-06	9.98e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CA—kidney cancer	8.2e-06	9.81e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—BCHE—kidney cancer	8.14e-06	9.74e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RAF1—kidney cancer	8.14e-06	9.73e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RELA—kidney cancer	8.1e-06	9.69e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—BCHE—kidney cancer	8.1e-06	9.68e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.08e-06	9.66e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—kidney cancer	8.05e-06	9.63e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.04e-06	9.62e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC5A5—kidney cancer	8e-06	9.56e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTP1—kidney cancer	7.96e-06	9.52e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MTOR—kidney cancer	7.95e-06	9.5e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.77e-06	9.29e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC2A1—kidney cancer	7.72e-06	9.24e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.69e-06	9.2e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL2—kidney cancer	7.63e-06	9.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ACHE—kidney cancer	7.61e-06	9.1e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTT1—kidney cancer	7.61e-06	9.1e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ABCB1—kidney cancer	7.54e-06	9.01e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.54e-06	9.01e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.49e-06	8.96e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1B—kidney cancer	7.46e-06	8.92e-05	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	7.36e-06	8.81e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HIF1A—kidney cancer	7.36e-06	8.81e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TSC2—kidney cancer	7.34e-06	8.79e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTM1—kidney cancer	7.32e-06	8.75e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL2—kidney cancer	7.3e-06	8.73e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SCARB1—kidney cancer	7.2e-06	8.61e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.18e-06	8.59e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS1—kidney cancer	7.13e-06	8.53e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—kidney cancer	7.11e-06	8.51e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—JUN—kidney cancer	7.1e-06	8.49e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CTNNB1—kidney cancer	7.04e-06	8.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PSMD7—kidney cancer	6.99e-06	8.36e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP1A1—kidney cancer	6.94e-06	8.3e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTEN—kidney cancer	6.87e-06	8.21e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—kidney cancer	6.83e-06	8.17e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—BCHE—kidney cancer	6.63e-06	7.93e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.57e-06	7.86e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.55e-06	7.83e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.53e-06	7.82e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—POMC—kidney cancer	6.51e-06	7.79e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APC—kidney cancer	6.49e-06	7.76e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KIT—kidney cancer	6.49e-06	7.76e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—kidney cancer	6.48e-06	7.75e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTP1—kidney cancer	6.48e-06	7.75e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTP1—kidney cancer	6.44e-06	7.7e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.32e-06	7.56e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—kidney cancer	6.2e-06	7.42e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.13e-06	7.34e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—MAPK3—kidney cancer	6.13e-06	7.34e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ABCB1—kidney cancer	6.13e-06	7.33e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—BRAF—kidney cancer	6.1e-06	7.29e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ABCB1—kidney cancer	6.1e-06	7.29e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTEN—kidney cancer	5.96e-06	7.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTM1—kidney cancer	5.95e-06	7.12e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTM1—kidney cancer	5.92e-06	7.08e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAPK3—kidney cancer	5.87e-06	7.02e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—MAPK1—kidney cancer	5.84e-06	6.98e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—kidney cancer	5.71e-06	6.83e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.7e-06	6.82e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.64e-06	6.75e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP1A1—kidney cancer	5.61e-06	6.71e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAPK1—kidney cancer	5.58e-06	6.68e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—kidney cancer	5.51e-06	6.59e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.35e-06	6.4e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—kidney cancer	5.27e-06	6.31e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTP1—kidney cancer	5.27e-06	6.31e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—kidney cancer	5.2e-06	6.21e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—POMC—kidney cancer	5.17e-06	6.19e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RAF1—kidney cancer	5.09e-06	6.09e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CA—kidney cancer	5.06e-06	6.06e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—kidney cancer	5.04e-06	6.02e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ABCB1—kidney cancer	4.99e-06	5.97e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MTOR—kidney cancer	4.97e-06	5.95e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD4—kidney cancer	4.96e-06	5.93e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—kidney cancer	4.9e-06	5.86e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTM1—kidney cancer	4.84e-06	5.8e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CA—kidney cancer	4.84e-06	5.79e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—kidney cancer	4.69e-06	5.61e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1B—kidney cancer	4.66e-06	5.58e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.64e-06	5.55e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.61e-06	5.51e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.59e-06	5.49e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTEN—kidney cancer	4.53e-06	5.42e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CTNNB1—kidney cancer	4.41e-06	5.27e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTEN—kidney cancer	4.29e-06	5.14e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—POMC—kidney cancer	4.21e-06	5.03e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CA—kidney cancer	4.2e-06	5.03e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—POMC—kidney cancer	4.18e-06	5e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.77e-06	4.51e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAPK3—kidney cancer	3.67e-06	4.39e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTEN—kidney cancer	3.6e-06	4.3e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—kidney cancer	3.57e-06	4.27e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAPK1—kidney cancer	3.49e-06	4.18e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—POMC—kidney cancer	3.42e-06	4.1e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—kidney cancer	3.36e-06	4.01e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—kidney cancer	3.34e-06	3.99e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—kidney cancer	3.3e-06	3.94e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CA—kidney cancer	3.2e-06	3.82e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CA—kidney cancer	3.03e-06	3.62e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTEN—kidney cancer	2.93e-06	3.5e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTEN—kidney cancer	2.91e-06	3.48e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—kidney cancer	2.73e-06	3.27e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CA—kidney cancer	2.54e-06	3.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTEN—kidney cancer	2.38e-06	2.85e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CA—kidney cancer	2.05e-06	2.46e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.68e-06	2.01e-05	CbGpPWpGaD
